Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2Gastrointestinal 2

Conditions

Colorectal Neoplasms 21Anus Neoplasms 17Carcinoma, Hepatocellular 11Appendiceal Neoplasms 11Stomach Neoplasms 10Neoplasm Metastasis 9Peritoneal Neoplasms 8Pancreatic Neoplasms 8Colonic Neoplasms 6Rectal Neoplasms 5Liver Neoplasms 5Anal Canal Carcinoma 4Ovarian Neoplasms 3Gastrointestinal Neoplasms 3Uterine Neoplasms 2Pseudomyxoma Peritonei 2Uterine Cervical Neoplasms 1Sarcoma 1Recurrence Hepatocellular Carcinoma 1Recurrence 1Pleural Neoplasms 1Peritoneal Diseases 1Neoplasms, Squamous Cell 1Neoplasms 1Necrosis 1Mesothelioma 1Mediastinal Neoplasms 1Locally Advanced Anal Canal Cancer 1Hyperthermia 1HIV Infections 1

Interventions

Surveys and Questionnaires 2Mitomycin 2Hyperthermic Intraperitoneal Chemotherapy 2irinotecan sucrosofate 1Specimen Handling 1Referral and Consultation 1Oxaliplatin 1Observation 1Nivolumab 1Magnetic Resonance Spectroscopy 1Leucovorin 1Lansoprazole 1Ipilimumab 1Floxuridine 1Cytoreduction Surgical Procedures 1Clarithromycin 1CTLA-4 Antigen 1Amoxicillin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Pseudomyxoma Peritonei × Mitomycin × Gastrointestinal × Clear all
NCT04779554 2026-04-01

Flat Dose vs. Weight-based IP Chemotherapy for CRS/HIPEC

University of Kentucky

Phase 2 Recruiting
100 enrolled
GastrointestinalGynecologic

Appendiceal Neoplasms, Peritoneal Neoplasms, Pseudomyxoma Peritonei, Colorectal Neoplasms

NCT02040142 2024-10-24

HIPEC for Peritoneal Carcinomatosis

Albert Einstein College of Medicine

Phase 2 Completed
51 enrolled 12 charts
GastrointestinalGynecologic

Appendiceal Neoplasms, Peritoneal Neoplasms, Pseudomyxoma Peritonei, Stomach Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡